Cellink taps into healthcare demand with $109m share sale
Shares in Cellink, the Swedish maker of 3D printing equipment for the life sciences industry, rose more than 4% on Thursday morning after the company completed a Skr946m ($109.2m) growth capital raising, amid strong investor appetite for exposure to the healthcare sector due to the global Covid-19 pandemic.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: